Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Faculty of Medical Sciences
    • About
    • Study
    • Research
    • Active parent page: News
    • Events
    • Contacts
    • Divisions and Institutes

UCL cancer researcher receives Agilent Thought Leader Award

Award recognizes transformative prostate cancer clinical research using cutting-edge liquid biopsy technologies.

2 August 2022

Professor Gert Attard, UCL Cancer Institute

Breadcrumb trail

  • Faculty of Medical Sciences

Faculty menu

  • About
  • Study
  • Research
  • Current page: News
  • Events
  • Contacts
  • Divisions and Institutes

Professor Gerhardt Attard from the UCL Cancer Institute has been selected to receive a prestigious Agilent Thought Leader Award for his work using cutting-edge liquid biopsy technology to identify biomarkers to monitor response to drugs and cancer progression in patients with advanced prostate cancer. The award, announced today by Agilent Technologies Inc. (NYSE: A), consists of financial and technical support, as well as instrumentation and reagents. Prof Attard is a John Black Charitable Foundation Endowed Chair in Urological Cancer Research at University College London (UCL).

Despite cases of significant initial response to treatment, metastatic prostate cancer usually develops treatment resistance. Liquid biopsies are non-invasive and therefore ideal to track both tumour response to therapy and evolution of cancer mutation. By understanding how tumours develop over time Professor Attard and his colleagues will be able to identify vulnerabilities in them that can be exploited and will design improved treatment combinations and sequences to reduce the risk of relapse.

Professor Attard said:

“The Agilent Thought Leader Award will support my group’s work on interrogating tumor epigenetic information contained in plasma DNA. As translational researchers, one of our key remits is to transition new discoveries into clinically-implemented tests. I am therefore thrilled to receive this award that is both a great honour and an important opportunity for my team and our collaborators to work with some of the industry leaders in the diagnostics field. My group primarily studies blood collected from men with advanced prostate cancer but I expect our findings to also have relevance to and support new tests for other cancer types. I am confident that this partnership will accelerate our delivery of diagnostics that give cancer physicians more precise information to tailor treatment paradigms and improve patient outcomes.”

Ronda Allen, head of R&D, Assays and Reagents, in the Diagnostics and Genomics Group at Agilent and the executive sponsor of the award, said: “Agilent continues to invest in research on the important segment markets we serve. The important work conducted through this award will support scientific developments in the cancer genomics space, and we believe Professor Attard will be a brilliant asset in that endeavor.”

Angharad Milenkovic, Vice-President Advancement at UCL, said:

“Philanthropic gifts like the Agilent Thought Leader Award are crucial to enabling UCL’s world-leading scientists to make impactful discoveries that could alter the clinical landscape for advanced prostate cancer patients. We’re grateful to our philanthropic partners at Agilent, who share our vision for improving cancer diagnosis and treatment, for their generous funding of Professor Attard’s research.”

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance quality of life. The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space. 

Professor Attard is an influential oncology clinician-scientist whose work has enabled the application of modern genomics clinical solutions, such as liquid biopsy, to create the next generation of diagnostics and prognostic tools in the fight against cancer. He holds an advanced Cancer Research UK Clinician Scientist award and is Team Leader of the Treatment Resistance Group at the UCL Cancer Institute.

Further information

  • Professor Gerhardt Attard
  • UCL Cancer Institute
  • To find out more about supporting Professor Attard’s work and prostate cancer research at UCL, please contact Sarah Medd-Phillips, Deputy Head of Major Gifts (Health) at s.medd-phillips@ucl.ac.uk.

Tweets by uclmedsci

Highlights in Medical Sciences

MS Aesthetics (Surgical Pathway) Scholarship
Concept image of female model overlaid with pattern of transparent hexagon

Scholarship

MS Aesthetics (Surgical Pathway) Scholarship

A new fee-waiver scholarship worth £16,000 for an outstanding UK / Home student to join the MS Aesthetics (Aesthetic Surgery) in September 2025.

11 June 2025

UCL Cancer Institute awarded Athena SWAN Gold
Athena Swan Gold Award

Award

UCL Cancer Institute awarded Athena SWAN Gold

The UCL Cancer Institute has been awarded Athena SWAN Gold in recognition of its sustained commitment to advancing gender equality in higher education and research.

20 May 2025

New Dean of Medical Sciences appointed
Professor Emma Morris

Announcement

New Dean of Medical Sciences appointed

Internationally recognised clinician scientist, Professor Emma Morris, will take up the role of Dean of UCL's Faculty of Medical Sciences in August 2025.

28 February 2025

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in